Drug Approval | December 12, 2022
Alembic receives USFDA final Approval for Desonide Cream
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Move to increase affordability and accessibility for heart failure patients across the country
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
This product is based on Osmotic Controlled Release Oral Delivery System technology
The joint venture will help both the parties to further develop the high-margin service business
Subscribe To Our Newsletter & Stay Updated
